7-75123250-A-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001003795.3(GTF2IRD2B):c.473A>C(p.Glu158Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001003795.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000175 AC: 22AN: 126008Hom.: 0 Cov.: 18
GnomAD3 exomes AF: 0.000150 AC: 29AN: 193376Hom.: 0 AF XY: 0.000187 AC XY: 20AN XY: 106940
GnomAD4 exome AF: 0.000160 AC: 204AN: 1278570Hom.: 5 Cov.: 20 AF XY: 0.000162 AC XY: 103AN XY: 637668
GnomAD4 genome AF: 0.000175 AC: 22AN: 126008Hom.: 0 Cov.: 18 AF XY: 0.000150 AC XY: 9AN XY: 59874
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.473A>C (p.E158A) alteration is located in exon 5 (coding exon 4) of the GTF2IRD2B gene. This alteration results from a A to C substitution at nucleotide position 473, causing the glutamic acid (E) at amino acid position 158 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at